The Enhanced Interactive Physical and Cognitive Exercise System (iPACES TM v2.0): Pilot Clinical Trial of an In-Home iPad-Based Neuro-Exergame for Mild Cognitive Impairment (MCI)

• Published in: Journal of clinical medicine Vol. 7; no. 9; p. 249
• Main Authors: Wall, Kathryn, Stark, Jessica, Schillaci, Alexa, Saulnier, Emilie T, McLaren, Elizabeth, Striegnitz, Kristina, Cohen, Brian D, Arciero, Paul J, Kramer, Arthur F, Anderson-Hanley, Cay
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 30.08.2018
• Subjects: exergame; older adult; cortisol; dementia; exercise; IGF-1; mild cognitive impairment; Alzheimer’s; executive function; neurocognitive disorder
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm7090249

Given increasing longevity worldwide, older adults and caregivers are seeking ways to curb cognitive decline especially for those with mild cognitive impairment (MCI, now mild neurocognitive disorder, mNCD, Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-V). This quasi-experimental, within-subjects pilot clinical trial was designed to replicate and extend the study of cognitive benefits for MCI by improving upon our prior interactive Physical and Cognitive Exercise Study (iPACES v1.0) by increasing the usability of the neuro-exergame and exploring possible underlying neurobiological mechanisms. Older adults were enrolled in a three-month, in-home trial of a portable neuro-exergame (iPACES™ v2.0) where participants pedaled and steered along a virtual bike path (Memory Lane™). Neuropsychological function was assessed at baseline after component familiarization intervals (e.g., two weeks of exercise-only, game-only, etc.) and after three months of interactive neuro-exergame intervention. Fourteen participants were enrolled in the study and seven completed the final evaluation. Intent-to-treat analyses were conducted with imputed missing data (total = 14). Significant improvement in executive function (Stroop) was found ( = 0.68, = 0.02) only. Changes in salivary biomarkers (cortisol and insulin-like growth factor 1; IGF-1) were significantly associated with improved cognition. Further research is needed, but pilot data suggest that a portable in-home neuro-exergame may be an additional, practical tool to fight back against cognitive decline and dementia.